Prophylactic Hepatitis B Virus Vaccines Market : Global Industry Analysis and Forecast 2016 - 2024

Transcription

Prophylactic Hepatitis B Virus Vaccines Market : Global Industry
Analysis and Forecast 2016 - 2024
Persistence Market Research
Prophylactic Hepatitis B Virus Vaccines
Market : Global Industry Analysis and
Forecast 2016 - 2024
1
Persistence Market Research Released New Market Report on “Prophylactic Hepatitis B
Virus Vaccines Market : Global Industry Analysis and Forecast 2016 - 2024”.
Hepatitis B virus (HBV) is disease related to the liver. Hepatitis B virus (HBV) infection results in
deaths due to liver cancer and liver failure. The hepatitis B vaccine is available for all age
groups to prevent HBV infection. The disease is caused due to transmission of Hepatitis B virus
(HBV) through contact with body fluids, blood and semen of an infected person. Hepatitis B
disease can cause acute and later may turn to chronic disease if not treated at early stage. In
2015, WHO estimated that 240 Mn people are infected with chronic hepatitis B virus. Every year
more than 780,000 deaths occur due to complexity of hepatitis B viral infection. This infection
caused by chronic hepatitis B virus develops fulminant hepatitis B (autoimmune disorder), liver
cirrhosis, hepatocellular carcinoma (liver cancer), liver failure which can be treated by a liver
transplant. The Global Alliance for Vaccines and Immunization (GAVI) provides direction and
support to prevent transmission through vaccination. However, there is a significant decrease in
incidence of hepatitis B virus infection after introduction of hepatitis B vaccine.
The prophylactic hepatitis B virus vaccines market is expected to grow remarkably during the
forecast period due to increasing prevalence and incidence of hepatitis B infection, increasing
public awareness (Patient Education Programs), government initiatives for promotion and
creating awareness about prophylactic hepatitis B vaccines. However, factors such as side
effects of the vaccine, high costs incurred during research and development and macroeconomic factors like stringent regulations can affect the market adversely.
Interested in report: Please follow the below links to meet your requirements; Request
for the Report Sample: http://www.persistencemarketresearch.com/samples/10571
The global prophylactic hepatitis b virus vaccines market is classified on the basis of end use
and geography.
2
Based on end use, the global prophylactic hepatitis B virus vaccines market is divided
into following:
•
Hospitals
•
Clinics
Ever since 1982, vaccines were available for prevention of hepatitis B viral infections and
currently more than 1 Bn doses of HBV vaccines have been distributed worldwide. The WHO
recommends that all infants should receive the hepatitis B vaccine within 24 hours of birth.
Thus, increase in the population base in APAC is expected to contribute significantly to the
growth of global prophylactic hepatitis B virus vaccines market.
Geographically, the global prophylactic hepatitis b virus vaccines market is segmented into five
key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North
America dominates the global prophylactic hepatitis B virus vaccines market followed by APAC
and Europe. According to WHO, globally more than 240 Mn people suffer from chronic hepatitis
B viral infection and about 780,000 people die every year due to consequences related with
HBV infection. Of these majority of people belong to developing nations of APAC, Latin America
and Africa. The prevalence is considerably low in countries with high level of living standards
such as the U.S., Canada, U.K., France, Germany, Italy and Spain.
Some of the major players operating in the market for prophylactic hepatitis B virus vaccines are
Merck & Co, Inc., Sanofi Pasteur, Novartis AG, Pfizer Inc., GlaxoSmithKline to name a few.
Vaccine market is an oligopolistic market in which the major players such as GlaxoSmithKline,
Merck & Co, Inc. and Sanofi Pasteur are using cost leadership and differentiating strategy. The
strategy of the major companies in the global prophylactic hepatitis B virus vaccines market is to
cut down the prices owing to the increased demand.
3
The report covers exhaustive analysis on:
•
Prophylactic Hepatitis B Virus Vaccines Market Segments
•
Prophylactic Hepatitis B Virus Vaccines Market Dynamics
•
Historical Actual Market Size, 2013 - 2015
•
Prophylactic Hepatitis B Virus Vaccines Market Size & Forecast 2016 to 2022
•
Prophylactic Hepatitis B Virus Vaccines Current Trends/Issues/Challenges
•
Competition & Companies involved
•
Prophylactic Hepatitis B Virus Vaccines Drivers and Restraints
Request TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/toc/10571
Regional analysis includes
•
North America
•
Latin America
•
Europe
•
Asia Pacific
•
Middle East & Africa
4
Report Highlights:
•
Shifting Industry dynamics
•
In-depth market segmentation
•
Historical, current and projected industry size Recent industry trends
•
Key Competition landscape
•
Strategies of key players and product offerings
•
Potential and niche segments/regions exhibiting promising growth
•
A neutral perspective towards market performance
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in
syndicated research, custom research, and consulting services. PMR boasts market research
expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and
Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping
and Transportation industries. The company draws from its multi-disciplinary capabilities and
high-pedigree team of analysts to share data that precisely corresponds to clients’ business
needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions.
From ready-to-purchase market research reports to customized research solutions, PMR’s
engagement models are highly flexible without compromising on its deep-seated research
values.
5
Contact Us:
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
6

Prophylactic Hepatitis B Virus Vaccines Market : Global Industry Analysis and Forecast 2016 - 2024

Transcription

Similar documents

PDF Version - 1.32 MB

Document 6522215

Health History - Newport Pulmonary Endocrine Associates

Where to from here? - Hepatitis Australia

The 2015 Novo Nordisk Prize Symposium on

Dear Friends, I hope you are all doing well, as always

Hepatitis B Virus (HBV) Therapeutics Market to Expand at a modest Compound Annual Growth Rate (CAGR) of 2.4% Up to 2024

APPLICATION FORM